| Literature DB >> 31487013 |
Maki Sakaguchi1,2, Yoshiko Nakano3, Mai Honda-Kitahara3, Masashi Kinoshita1, Shingo Tanaka1, Masahiro Oishi1, Kazuhiro Noguchi4, Masaki Fukuda4, Hideaki Maeba4, Takuya Watanabe5, Yutaka Hayashi5, Hiroko Ikeda2, Hiroshi Minato6, Koichi Ichimura3, Takayuki Nojima2, Mitsutoshi Nakada7.
Abstract
Rhabdomyosarcoma is the most common soft-tissue sarcoma affecting children and adolescents. It is defined as a malignant neoplasm characterized by morphologic, immunohistochemical, ultrastructural, or molecular genetic evidence of primary skeletal muscle differentiation, usually in the absence of any other pattern of differentiation. Primary intracranial rhabdomyosarcoma (PIRMS) is an extremely rare neoplasm, with only 60 cases reported in the literature, and generally has poor prognosis with an overall survival of only 9.1 months. The DICER1 gene encodes an RNA endoribonuclease that plays a key role in gene expression regulation through the production of small RNAs. Herein, we report two cases of PIRMS with somatic DICER1 mutation showing morphological and immunohistochemical evidence of primary skeletal muscle differentiation; the two cases share common clinical features, including young age, supratentorial tumor, and onset of intratumoral bleeding. Although methylation profiling was not performed, both cases shared clinical and pathological characteristics in common with recently proposed methylation entity "spindle cell sarcoma with rhabdomyosarcoma-like features, DICER1 mutant (SCS-RMSlike-DICER1)''. Our cases provide further evidence of the link between primary intracranial sarcoma and DICER1 mutation which may form a distinct entity.Entities:
Keywords: DICER1; Hematoma; Rhabdomyosarcoma; SCS-RMSlike-DICER1; Supratentorial
Mesh:
Substances:
Year: 2019 PMID: 31487013 DOI: 10.1007/s10014-019-00352-z
Source DB: PubMed Journal: Brain Tumor Pathol ISSN: 1433-7398 Impact factor: 3.298